Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that future changes to the (a) soft drinks industry levy and (b) other measures relating to sugar are responsive to the needs of people with Type 1 Diabetes who require continued access to affordable high sugar foods.

The prevention of ill health is a priority for the Government. We are committed to tackling obesity as a core part of our health mission, to support people to live longer, healthier lives and raise the healthiest generation of children.

Most of the population are consuming double the free sugar recommendations of 5% total daily calorie intake. Diets high in sugar increase the risk of tooth decay and weight gain. Being overweight or living with obesity is associated with a range of negative health impacts such as type 2 diabetes, cardiovascular diseases and some kinds of cancers.

People with type 1 diabetes should only consume high sugar drinks in the event of hypoglycaemia, because of not eating enough carbohydrates or taking too much insulin. With proper management, hypoglycaemia should be a rare event, and the consumption of high sugar drinks kept to a minimum. In addition, high sugar drinks are available at a variety of price points.

Diabetes UK has provided an online summary of the Soft Drinks Industry Levy (SDIL) and put this in the context of diabetes and its management. It includes advice on the use of drinks to treat hypoglycaemia and highlights that other products can also be used for this purpose e.g. glucose tablets, sweets such as jelly babies, pure fruit juice or glucose gels. It also highlights that some treatments may be prescribed for free for people with diabetes. Further information can be found at the following link:

https://www.diabetes.org.uk/living-with-diabetes/eating/sugar-reduction-hypo-treatment-sugar-tax

NHS England is supporting integrated care boards (ICBs) to improve treatment and care for their populations and reduce variation of diabetes care, with NHS England supporting systems to be aware of the national data and insights through benchmarking and promoting good practice. NHS England has provided £3 million of funding to systems to provide clinical leadership to ensure that clinical diabetes metrics, such as care processes and treatment targets, are reviewed at ICB level and unwarranted variation identified. A resource hub of materials has been set up on Future NHS, including examples of innovation and best practice for improvement of care process delivery, and achievement of treatment targets.

The SDIL came into force in 2018 and applies to producers and importers of added sugar soft drinks that contain 5 grams total sugar or more per 100 millilitres. If the currently proposed change to the lower sugar threshold comes into force, it will only impact around 17% of additional sales volumes for products containing between 4 and 4.9 grams of sugar per 100 millilitres. The only change impacting high sugar drinks is the uprating of the tax rate, and with both these changes it is up to businesses to decide whether to pass through to consumers any additional costs associated with paying the tax.